Oruka Therapeutics, Inc. ORKA Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$105.43M+25.6% | -$141.67M-2,553% | -$5.34M+46.2% | -$9.93M+48.6% | ||
| $83K+88.6% | $44K+193% | $15K-25.0% | $20K+25.0% | ||
| $24.24M-5.1% | $25.54M+3,623% | $686K+23.4% | $556K+11.9% | ||
| -$88.21M+18.5% | -$108.23M-2,058% | -$5.01M+54.1% | -$10.91M+41.8% | ||
| $209K— | —— | $0— | —— | ||
| -$96.75M+70.7% | -$330.3M— | —— | —— | ||
| —— | $953.84M— | —— | $0— | ||
| -$14.64M-103% | $486.04M+9,794% | -$5.01M+54.1% | -$10.91M— | ||
| -$88.42M— | —— | -$5.01M+54.1% | -$10.91M+42.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Oruka Therapeutics, Inc. generate?
- Oruka Therapeutics, Inc. (ORKA) generated -$90.9M in operating cash flow over the trailing twelve months.
- What is Oruka Therapeutics, Inc.'s free cash flow?
- After $269.0K of capital expenditures, Oruka Therapeutics, Inc.'s free cash flow was -$91.2M over the trailing twelve months, up 23.6% year over year.
- Where does Oruka Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Oruka Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.